| scholarly article | Q13442814 |
| systematic review | Q1504425 |
| meta-analysis | Q815382 |
| P6179 | Dimensions Publication ID | 1006777324 |
| P356 | DOI | 10.1186/2046-4053-2-18 |
| P932 | PMC publication ID | 3610251 |
| P698 | PubMed publication ID | 23497523 |
| P5875 | ResearchGate publication ID | 236051960 |
| P50 | author | Keshena Malik | Q125192720 |
| Karin Kirmayr | Q125193144 | ||
| Gordon Guyatt | Q5585214 | ||
| Victor Montori | Q7926167 | ||
| Kristian Thorlund | Q30089886 | ||
| Ivan A. Steenstra | Q30349394 | ||
| Jason W. Busse | Q30349396 | ||
| Malgorzata M Bala | Q90269358 | ||
| Stephen J Burnie | Q125192693 | ||
| David Brunarski | Q125192707 | ||
| Stefan Schandelmaier | Q32035270 | ||
| P2093 | author name string | Shanil Ebrahim | |
| Paul Alexander | |||
| John J Riva | |||
| Peter Struijs | |||
| Markus Faulhaber | |||
| Paul Bruno | |||
| Gaelan Connell | |||
| Milosz Jankowski | |||
| Daniel Avrahami | |||
| Vishalini Sivarajah | |||
| Eric A Coomes | |||
| Quenby Mahood | |||
| Trung Ngo | |||
| Wiktoria Lesniak | |||
| David Torrance | |||
| Frances LeBlanc | |||
| P2860 | cites work | Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials | Q21261358 |
| Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q21562278 | ||
| Sifting the evidence-what's wrong with significance tests? | Q24524896 | ||
| Grading quality of evidence and strength of recommendations | Q24562409 | ||
| What is "quality of evidence" and why is it important to clinicians? | Q24647929 | ||
| Prospective epidemiological observations on the course of the disease in fibromyalgia patients | Q24800097 | ||
| Measuring inconsistency in meta-analyses | Q27860655 | ||
| Quantifying heterogeneity in a meta-analysis | Q27860672 | ||
| GRADE: an emerging consensus on rating quality of evidence and strength of recommendations | Q27860753 | ||
| Assessing the quality of reports of randomized clinical trials: is blinding necessary? | Q27860973 | ||
| Antidepressant therapy for unexplained symptoms and symptom syndromes | Q28142298 | ||
| Indirect comparisons of competing interventions | Q28183606 | ||
| Improving depiction of benefits and harms: analyses of studies of well-known therapeutics and review of high-impact medical journals | Q28222409 | ||
| GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables | Q29547885 | ||
| The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee | Q29618782 | ||
| The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials | Q29619501 | ||
| Interaction revisited: the difference between two estimates | Q29619619 | ||
| Alternative and complementary therapies in fibromyalgia syndrome | Q30369322 | ||
| Treatment of fibromyalgia with antidepressants: a meta-analysis. | Q30940465 | ||
| Comparative efficacy of pharmacological and non-pharmacological interventions in fibromyalgia syndrome: network meta-analysis | Q31070302 | ||
| Analyzing multiple endpoints in clinical trials of pain treatments: IMMPACT recommendations. Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials | Q37244975 | ||
| Interpreting the clinical importance of group differences in chronic pain clinical trials: IMMPACT recommendations | Q37616606 | ||
| Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations | Q37703919 | ||
| Specific instructions for estimating unclearly reported blinding status in randomized trials were reliable and valid | Q37971411 | ||
| Placebo and nocebo responses in randomised controlled trials of drugs applying for approval for fibromyalgia syndrome treatment: systematic review and meta-analysis. | Q38058633 | ||
| Pooling health-related quality of life outcomes in meta-analysis-a tutorial and review of methods for enhancing interpretability | Q38523890 | ||
| Why do doctors find some patients difficult to help? | Q40765330 | ||
| Primary fibromyalgia syndrome--an outcome study | Q40873276 | ||
| Prevalence of fibromyalgia: a survey in five European countries | Q43407868 | ||
| Pharmacological treatment of fibromyalgia syndrome | Q46610384 | ||
| Systematic review of pharmacologic treatment in fibromyalgia | Q46864331 | ||
| Chronic widespread musculoskeletal pain - a comparison of those who meet criteria for fibromyalgia and those who do not. | Q46892522 | ||
| Identifying important outcome domains for chronic pain clinical trials: an IMMPACT survey of people with pain | Q48454274 | ||
| A meta-analysis of fibromyalgia treatment interventions | Q48743145 | ||
| Fibromyalgia versus rheumatoid arthritis: a longitudinal comparison of the quality of life. | Q48825529 | ||
| How to use an article reporting a multiple treatment comparison meta-analysis. | Q53106594 | ||
| Is the Jadad score the proper evaluation of trials? | Q55042284 | ||
| The prevalence and characteristics of fibromyalgia in the general population. | Q55065269 | ||
| Medically unexplained symptoms--GPs' attitudes towards their cause and management | Q57356975 | ||
| Developing patient-reported outcome measures for pain clinical trials: IMMPACT recommendations | Q59351353 | ||
| Physiotherapie, medizinische Trainingstherapie und physikalische Therapie beim Fibromyalgiesyndrom | Q60679271 | ||
| Psychotherapie bei Patienten mit Fibromyalgiesyndrom | Q60679274 | ||
| Health status and disease severity in fibromyalgia. Results of a six-center longitudinal study | Q60680857 | ||
| Work and disability status of persons with fibromyalgia | Q73442155 | ||
| Unexplained symptoms in primary care: perspectives of doctors and patients | Q73954851 | ||
| The London Fibromyalgia Epidemiology Study: the prevalence of fibromyalgia syndrome in London, Ontario | Q78000579 | ||
| Are antidepressants effective in fibromyalgia? | Q78822878 | ||
| Prevalence of musculoskeletal conditions in an Italian population sample: results of a regional community-based study. I. The MAPPING study | Q82190500 | ||
| Multicomponent therapy for treatment of fibromyalgia syndrome | Q33332502 | ||
| Amitriptyline in the treatment of fibromyalgia: a systematic review of its efficacy | Q33359484 | ||
| The effectiveness of hydrotherapy in the management of fibromyalgia syndrome: a systematic review | Q33364137 | ||
| A systematic review on the effectiveness of treatment with antidepressants in fibromyalgia syndrome | Q33365100 | ||
| Treatment of fibromyalgia syndrome with antidepressants: a meta-analysis | Q33399660 | ||
| Efficacy of multicomponent treatment in fibromyalgia syndrome: a meta-analysis of randomized controlled clinical trials | Q33403803 | ||
| Prevalence of fibromyalgia in a low socioeconomic status population | Q33463851 | ||
| Treatment of fibromyalgia syndrome with gabapentin and pregabalin--a meta-analysis of randomized controlled trials | Q33470807 | ||
| Efficacy of acupuncture for the treatment of fibromyalgia: systematic review and meta-analysis of randomized trials | Q33480507 | ||
| Antidepressant treatment of fibromyalgia. A meta-analysis and review | Q33882770 | ||
| Multidisciplinary rehabilitation for fibromyalgia and musculoskeletal pain in working age adults | Q33908387 | ||
| A review of recent clinical trials of the nutritional supplement Chlorella pyrenoidosa in the treatment of fibromyalgia, hypertension, and ulcerative colitis. | Q33946317 | ||
| Acupuncture for fibromyalgia--a systematic review of randomized clinical trials | Q34001627 | ||
| A systematic review and mixed treatment comparison of the efficacy of pharmacological treatments for fibromyalgia | Q34003097 | ||
| Physical therapy in the treatment of fibromyalgia. | Q34058453 | ||
| Mind-body therapies for the treatment of fibromyalgia. A systematic review | Q34112549 | ||
| Improving the interpretation of quality of life evidence in meta-analyses: the application of minimal important difference units | Q34222026 | ||
| Treatment of fibromyalgia with cyclobenzaprine: A meta-analysis | Q34297118 | ||
| Management of fibromyalgia syndrome | Q34368422 | ||
| Systematic review of randomized controlled trials of nonpharmacological interventions for fibromyalgia | Q34827493 | ||
| Chiropractic management of fibromyalgia syndrome: a systematic review of the literature | Q34914703 | ||
| Chiropractic treatment for fibromyalgia: a systematic review | Q34988111 | ||
| A comprehensive review of 46 exercise treatment studies in fibromyalgia (1988-2005). | Q35065889 | ||
| The burden of musculoskeletal diseases in the general population of Spain: results from a national survey | Q35549907 | ||
| Core outcome domains for chronic pain clinical trials: IMMPACT recommendations | Q35601771 | ||
| Core outcome measures for chronic pain clinical trials: IMMPACT recommendations | Q35994723 | ||
| Bayesian methods for evidence synthesis in cost-effectiveness analysis | Q36381197 | ||
| Going from evidence to recommendations | Q36645665 | ||
| A meta-analysis of the efficacy of fibromyalgia treatment according to level of care | Q36955370 | ||
| Evaluation of networks of randomized trials | Q36966424 | ||
| Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations | Q37022616 | ||
| Exercise for fibromyalgia: a systematic review | Q37157475 | ||
| P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | fibromyalgia | Q540571 |
| P304 | page(s) | 18 | |
| P577 | publication date | 2013-01-01 | |
| P1433 | published in | Systematic Reviews | Q18216009 |
| P1476 | title | Systematic review and network meta-analysis of interventions for fibromyalgia: a protocol | |
| P478 | volume | 2 |
| Q35914017 | Evaluation of a self-management patient education program for patients with fibromyalgia syndrome: study protocol of a cluster randomized controlled trial |
| Q47790569 | Meditation awareness training for the treatment of fibromyalgia syndrome: A randomized controlled trial. |
| Q39276381 | The addition of upper cervical manipulative therapy in the treatment of patients with fibromyalgia: a randomized controlled trial |
Search more.